Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · August 16, 2022

Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma

Journal of asthma and allergy

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of asthma and allergy
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
J Asthma Allergy 2022 Aug 01;15(2022)565-577, P Rogliani, F Cavalli, A Chetta, M Cazzola, L Calzetta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading